check this out: Summary of Transaction from 2014 news Concurrent with the completion of the alternative public offering, the Company closed on the sale of 21,500,000 units at a price of $1.00 per unit, resulting in $21.5 million in gross proceeds http://otd.harvard.edu/news/enumeral-biomedical-raises-215-million-from-new-and-current-investors-begin